Increased levels of transforming growth factor-β in HIV-associated nephropathy

Kidney International

Volumn 55, Issue 2, 1999, Pages 579-592

  Yamamoto, Tatsuo ^a,b,c,d,e   Noble, Nancy A ^a,b,c,d,e   Miller, Diane E ^a,b,c,d,e   Gold, Leslie I ^a,b,c,d,e   Hishida, Akira ^a,b,c,d,e   Nagase, Mitsumasa ^a,b,c,d,e   Cohen, Arthur H ^a,b,c,d,e   Border, Wayne A ^a,b,c,d,e,f  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Fibrosis; Glomerulonephritis; HIV nephropathy; Kidney disease; Matrix accumulation; Tat; TGF

Indexed keywords

MATRIX PROTEIN; MESSENGER RNA; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY DISEASE; MESANGIUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032954078     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00296.x     Document Type: Article

References (56)

1. 1. HUMPHREYS MH: Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 48:311-320, 1995
2. 2. COHEN AH, NAST CC: HIV-associated nephropathy: A unique combined glomerular, tubular and interstitial lesion. Modern Pathol 1:87-97, 1987
3. 3. D'AGATI V, SUH JI, CARBONE L, CHENG JT, APPEL G: Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35:1358-1370, 1989
4. 4. RAO TKS, FILIPPONE EJ, NICASTRI AD, LANDESMAN SH, FRANK E, CHEN CK,FRIEDMAN EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310:669-673, 1984
5. 5. D'AGATI V, APPEL GB: HIV infection and the kidney. J Am Soc Nephrol 8:138-152, 1997
6. 6. KOPP JB, KLOTMAN ME, ADLER SH, BRUGGEMAN LA, ECKHAUS M, DICKIE P, MARINOS NJ, BRYANT JL, NOTKINS AL, KLOTMAN PE: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for HIV-1 genes. Proc Natl Acad Sci USA 89:1577-1581, 1992
7. 7. KOPP JB, RAY PE, ADLER SH, BRUGGEMAN LA, MANGURIAN CV, OWENS JW, ECKHAUS MA, BRYANT JL, KLOTMAN PE: Nephropathy in HIV-transgenic mice, in Extracellular Matrix in the Kidney: Contrib Nephrol (Vol. 107), edited by KOIDE H, HAYASHI T, Basel, Elsevier, 1994, pp 194-204
8. 8. RAPPAPORT J, KOPP JB, KLOTMAN PE: Host virus interactions and the molecular regulation of HIV-1: Role in the pathogenesis of HIV-associated nephropathy. Kidney Int 46:16-27, 1994
9. 9. KEHRL JH, WAKEFIELD LM, ROBERT AB, JAKOWLEW SB, ALVAREZ-MON M, DERYNCK R, SPORN MB, FAUCI AS: Production of transforming growth factor beta by human lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163:1037-1050, 1986
10. 10. KEKOW J, WACHSMAN W, MCCUTCHAN JA, CRONIN M, CARSON DA, LOTZ M: Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci USA 87:8321-8325, 1990
11. 11. KEKOW J, WACHSMAN W, MCCUTCHAN JA, GROSS WL, ZACHARIAH M, CARSON DA, LOTZ M: Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. J Clin Invest 87:1010-1016, 1991
12. 12. ALLEN JB, WONG HL, GUYRE PM, SIMON GL, WAHL SM: Association of circulating receptor FCRIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-β. J Clin Invest 87:1773-1779, 1991
13. 13. WAHL SM, ALLEN JB, MCCARTNEY-FRANCIS N, MORGANTI-KOSSMAN MC, ORENSTEIN JM: Macrophage- and astrocyte-derived transforming growth factor-β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 173:981-991, 1991
14. 14. POLI G, KINTER AL, JUSTEMENT JS, BRESSLER P, KEHRL JH, FAUCI AS: Transforming growth factor-β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 173:589-597, 1991
15. 15. LAZDINS JK, KLIMKAIT T, ALTERI E, WALKER M, WOODS CK, COX D, BILBE G, SHIPMAN R, CERLETTI N, MCMASTER G: TGF-beta: Upregulator of HIV replication in macrophages. Res Virol 142:239-242, 1991
16. 16. LOTZ M, SETH P: TGF beta and HIV infection. Ann NY Acad Sci 685:501-511, 1993
17. 17. KEHRL JH, ROBERT AB, WAKEFIELD LM, JACKOWLEW SB, SPORN MB, FAUCI AS: Transforming growth factor beta is an immunomodulatory protein for human B-lymphocytes. J Immunol 137: 3855-3860, 1986
18. 18. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462, 1990
19. 19. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
20. 20. YAMAMOTO T, NAKAMURA T, NOBLE NA, RUOSLAHTI E, BORDER WA: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
21. 21. BORDER WA, NOBLE NA: Transforming growth factor-β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
22. 22. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
23. 23. ZAULI G, DAVIS BR, RE MC, VISANI G, FURLINI G, LA PLACA M: Tat protein stimulates production of transforming growth factor-β 1 by marrow macrophages: A potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 80:3036-3043, 1992
24. 24. CUPP C, TAYLOR JP, KHALILI K, AMINI S: Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene 8:2231-2236, 1993
25. 25. RASTY S, THATIKUNTA P, GORDON J, KHALILI K, AMINI S, GLORIOSO JC: Human immunodeficiency virus tat gene transfer to the murine central nervous system using a replication-defective herpes simplex virus vector stimulates transforming growth factor beta 1 gene expression. Proc Natl Acad Sci USA 92:6073-6078, 1996
26. 26. PELTON RW, SAXENA B, JONES M, MOSES HL, GOLD LI: Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: Expression patterns suggest multiple roles during embryonic development. J Cell Biol 115:1091-1105, 1991
27. 27. MILLER DA, LEE A, MATSUI Y, CHEN EY, MOSES HL, DERYNCK R: Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF-beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol 3:1926-1934, 1989
28. 28. PARMENTIER HK, VAN WICHEN DF, MEYLING FH, GOUDSMIT J, SCHUURMAN HJ: Epitopes of human immunodeficiency virus regulatory proteins tat, nef, and rev are expressed in normal human tissue. Am J Pathol 141:1209-1216, 1992
29. 29. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
30. 30. DERYNCK R, JARRET JA, CHEN EY, GOEDDEL DV: The murine transforming growth factor-β precursor. J Biol Chem 261:4377-4379, 1986
31. 31. GENOVESE C, ROWE D, KREAM B: Construction of DNA sequences complementary to rat α1 and α2 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dehydroxyvitamin D. Biochemistry 23:6210-6216, 1984
32. 32. FISHER LW, TERMINE JD, YOUNG MF: Deduced protein sequences of small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J Biol Chem 264:4571-4576, 1989
33. 33. FORT PH, MARTY L, PIECHACZYK M, SABROUTY SEI, DANI CH, JEANTEUR PH, BLANCHARD JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase mutagenic family. Nucl Acids Res 13:1431-1443, 1985
34. 34. PETERS H, BORDER WA, NOBLE NA: Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade. Kidney Int (in press)
35. 35. ISAKA Y, FUJIWARA Y, UEDA N, KANEDA Y, KAMADA T, IMAI E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
36. 36. SANDERSON N, FACTOR V, NAGY P, KOPP J, KONDAIAH P, WAKEFIELD L, ROBERTS AB, SPORN MB, THORGEIRSSON SS: Hepatic expression of mature TGF-β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572-2576, 1995
37. 37. KOPP JB, FACTOR VM, MOZES M, NAGY P, SANDERSON N, BÖTTINGER KLOTMAN PE, THORGEIRSSON SS: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
38. 38. BÓDI I, KIMMEL ABRAHAM AA, SVETKEY LP, KLOTMAN PE, KOPP JB: Renal TGF-β in HIV-associated kidney diseases. Kidney Int 51:1568-1577, 1997
39. 39. BALZA E, BORSI L, ALLEMANNI G, ZARDI L: Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett 228:42-44, 1988
40. 40. TOMOOKA S, BORDER WA, MARSHALL BC, NOBLE NA: Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int 42:1462-1469, 1992
41. 41. BARICOS WH, CORTEZ SL, EL-DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
42. 42. ABE M, HARPEL JG, METZ CN, NUNES I, LUSKUTOFF DJ, RIFKIN DB: An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promote 4-luciferase construct. Anal Biochem 216:276-284, 1994
43. 43. TAYLOR JP, CUPP C, DIAZ A, CHOWDHURY M, KHALILI K, JIMENEZ SA, AMINI S: Activation of expression of genes coding for extracellular matrix proteins in Tat-producing glioblastoma cells. Proc Natl Acad Sci USA 89:9617-9621, 1992
44. 44. FRANKEL AD, PABO CO: Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55:1189-1193, 1988
45. 45. ENSOLI B, BARILLARI G, SALAHUDDIN SZ, GALLO RC, WONG-STAAL F: Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84-86, 1990
46. 46. BARILLARI G, GENDELMAN R, GALLO RC, ENSOLI B: The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 90:7941-7945, 1993
47. 47. COHEN AH, SUN NCJ, SHAPSAK P, IMAGAWA DT: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mol Pathol 2:125-128, 1989
48. 48. KIMMEL PL, FERREIRA-CENTENO A, FARKAS-SZALLASI T, ABRAHAM AA, GARRETT CT: Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int 43:1347-1352, 1993
49. 49. BRUGGEMAN LA, DIKMAN S, MENG C, QUAGGIN SE, COFFMAN TM, KLOTMAN PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100:84-92, 1997
50. 50. BODI I, ABRAHAM AA, KIMMEL PL: Apoptosis in human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 26:286-291, 1995
51. 51. KIMMEL PL, MISHKIN GJ, UMANA WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28:202-208, 1996
52. 52. BURNS GC, PAUL SK, TOTH IR, SIVAK SL: Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8:1140-1146, 1997
53. 53. NOBLE NA, BORDER WA: Angiotensin II in renal fibrosis: Should TGF-β rather than blood pressure be the therapeutic target? Semin Nephrol 17:455-486, 1997
54. 54. BORDER WA, NOBLE NA: Interactions of TGF-β and angiotensin II in renal fibrosis. Hypertension S31:181-188, 1998
55. 55. PETERSON PK, GEKKER G, CHAO CC, SCHUT R, MOLITOR TW, BALFOUR HH JR: Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell coculture: Involvement of transforming growth factor-beta. J Immunol 146:81-84, 1991
56. 56. SHUKLA RR, KUMAR A, KIMMEL PL: Transforming growth factor beta increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 44:1022-1029, 1993